SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-009491
Filing Date
2024-03-27
Accepted
2024-03-27 08:00:14
Documents
16
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20240323_8k.htm   iXBRL 8-K 31561
2 EXHIBIT 99.1 ex_645776.htm EX-99.1 23868
7 ex_645776img001.jpg GRAPHIC 2201
  Complete submission text file 0001437749-24-009491.txt   202263

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240327.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240327_def.xml EX-101.DEF 11808
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240327_lab.xml EX-101.LAB 15859
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240327_pre.xml EX-101.PRE 12023
19 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240323_8k_htm.xml XML 2945
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 24785835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)